SBP, systolic blood pressure

SBP,收缩压
  • 文章类型: Journal Article
    蛋白酶体抑制剂(PIs)是多发性骨髓瘤和AL淀粉样变性患者联合治疗的骨干,同时也出现在Waldenström巨球蛋白血症和其他恶性肿瘤中。PIs作用于蛋白酶体肽酶,由于积累聚集而导致蛋白质组不稳定,展开,和/或受损的多肽;持续的蛋白质组不稳定性然后诱导细胞周期停滞和/或细胞凋亡。卡菲佐米,静脉内不可逆PI,与口服给药的Ixazomib或静脉内可逆性PI如硼替佐米相比,表现出更严重的心血管毒性特征。心血管毒性包括心力衰竭,高血压,心律失常,和急性冠脉综合征。因为PI是血液系统恶性肿瘤和淀粉样变性治疗的关键组成部分,管理他们的心血管毒性包括识别有风险的患者,在临床前水平早期诊断毒性,并在需要时提供心脏保护。未来的研究需要阐明潜在的机制,改善风险分层,定义最优管理策略,并开发具有安全心血管特征的新PI。
    Proteasome inhibitors (PIs) are the backbone of combination treatments for patients with multiple myeloma and AL amyloidosis, while also indicated in Waldenström\'s macroglobulinemia and other malignancies. PIs act on proteasome peptidases, causing proteome instability due to accumulating aggregated, unfolded, and/or damaged polypeptides; sustained proteome instability then induces cell cycle arrest and/or apoptosis. Carfilzomib, an intravenous irreversible PI, exhibits a more severe cardiovascular toxicity profile as compared with the orally administered ixazomib or intravenous reversible PI such as bortezomib. Cardiovascular toxicity includes heart failure, hypertension, arrhythmias, and acute coronary syndromes. Because PIs are critical components of the treatment of hematological malignancies and amyloidosis, managing their cardiovascular toxicity involves identifying patients at risk, diagnosing toxicity early at the preclinical level, and offering cardioprotection if needed. Future research is required to elucidate underlying mechanisms, improve risk stratification, define the optimal management strategy, and develop new PIs with safe cardiovascular profiles.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    初始直立性低血压是老年人的临床相关综合征,与直立性不耐受症状有关。本系统评价的目的是确定初始体位性低血压的老年人体位不耐受症状的患病率。
    MEDLINE(自1946年起),EMBASE(从1974年开始)和Cochrane被搜索到12月6日,2019年使用术语“初始直立性低血压”,“体位性低血压”和“老年人”。研究选择涉及以下标准:以英语发表;平均年龄或中位年龄≥65岁,初始直立性低血压的诊断包括在姿势改变后的最多1分钟内收缩压降低≥40mmHg和/或舒张压降低≥20mmHg。
    在8311篇文章中,纳入了12篇报告3446名平均年龄为75(6SD)岁的参与者(56.5%为女性)的初始直立性低血压患病率的文章。使用了五个初始的直立性低血压定义变化,并在六篇文章中报告了症状(968名参与者,平均年龄73.4(6.1标准差)岁,56%女性)。初始体位性低血压的老年人症状的患病率为24%至100%,取决于时间的变化或初始体位性低血压定义中的症状。
    在报告体位不耐受症状的地方,大部分被诊断为初始直立性低血压的老年人有症状.然而,关于初始直立性低血压和直立性不耐受症状的文献很少,并且使用了各种初始直立性低血压的定义。
    UNASSIGNED: Initial orthostatic hypotension is a clinically relevant syndrome in older adults which has been associated with symptoms of orthostatic intolerance. The aim of this systematic review was to determine the prevalence of orthostatic intolerance symptoms in older adults with initial orthostatic hypotension.
    UNASSIGNED: MEDLINE (from 1946), EMBASE (from 1974) and Cochrane were searched to December 6th, 2019 using the terms \"initial orthostatic hypotension\", \"postural hypotension\" and \"older adults\". Study selection involved the following criteria: published in English; mean or median age ≥ 65 years and diagnosis of initial orthostatic hypotension encompassed a decrease in systolic blood pressure by ≥ 40  mmHg and/or diastolic blood pressure by ≥ 20  mmHg within a maximum of 1 min following a postural change.
    UNASSIGNED: Of 8311 articles, 12 articles reporting initial orthostatic hypotension prevalence in 3446 participants with a mean age of 75 (6 SD) years (56.5% female) were included. Five initial orthostatic hypotension definition variations were utilised and symptoms were reported in six articles (968 participants, mean age 73.4 (6.1 SD) years, 56% female). The prevalence of symptoms in older adults with initial orthostatic hypotension ranged from 24 to 100% and was dependent on variations in timing or the inclusion of symptoms in the initial orthostatic hypotension definition.
    UNASSIGNED: Where orthostatic intolerance symptoms were reported, a large proportion of older adults with a diagnosis of initial orthostatic hypotension were symptomatic. However, the literature on initial orthostatic hypotension and orthostatic intolerance symptoms is scarce and a variety of definitions of initial orthostatic hypotension are utilised.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    UNASSIGNED: We reviewed the literature on interventions for patients with medically refractory chronically occluded internal carotid artery (COICA) to assess the risks and/or benefits after recanalization via an endovascular technique (ET) or hybrid surgery (HS, i.e., ET plus carotid endarterectomy).
    UNASSIGNED: A systematic search of the electronic databases was performed. Patients with COICA were classified into 4 different categories according to Hasan et al classification.
    UNASSIGNED: Eighteen studies satisfied the inclusion criteria. Only 6 studies involved an HS procedure. We identified 389 patients with COICA who underwent ET or HS; 91% were males. The overall perioperative complication rate was 10.1% (95% confidence interval [CI]: 7.4%-13.1%). For types A and B, the successful recanalization rate was 95.4% (95% CI: 86.5%-100%), with a 13.7% (95% CI: 2.3%-27.4%) complication rate. For type C, the success rate for ET was 45.7% (95% CI: 17.8%-70.7%), with a complication rate of 46.0% (95% CI: 20.0%-71.4%) for ET and for the HS technique 87.6% (95% CI: 80.9%-94.4%), with a complication rate of 14.0% (95% CI: 7.0%-21.8%). For type D, the success rate of recanalization was 29.8% (95% CI: 7.8%-52.8%), with a 29.8% (95% CI: 6.1%-56.3%) complication rate. Successful recanalization resulted in a symmetrical perfusion between both cerebral hemispheres, resolution of penumbra, normalization of the mean transit time, and improvement in Montreal Cognitive Assessment (MoCA) score (ΔMoCA = 9.80 points; P = 0.004).
    UNASSIGNED: Type A and B occlusions benefit from ET, especially in the presence of a large penumbra. Type C occlusions can benefit from HS. Unfortunately, we did not identify an intervention to help patients with type D occlusions. A phase 2b randomized controlled trial is needed to confirm these findings.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号